Testing a new lab method for diagnosing bile duct cancer
Part of Cancer clinical trials.
This study is testing a new lab technique to see if it can accurately diagnose a type of bile duct cancer called cholangiocarcinoma from stored tissue samples. It might help doctors diagnose this cancer more accurately in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a narrowing of the bile duct (biliary stenosis) that doctors didn't yet know the cause of.
- You had a sample taken from the bile duct (biopsy or brushing) and that sample is stored in a special way (formalin-fixed, paraffin-embedded).
- At least one year has passed since your sample was taken.
- You do not have pancreatic cancer that was confirmed from your sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This study looks at a new way to detect bile duct cancer (cholangiocarcinoma) using samples taken during a routine ERCP. It tests a special protein marker that might help doctors diagnose the condition more accurately.
This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.